Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
AOD-9604 20 mg $135.00 Out of stock Want to be notified when this product is back in stock
Quick service and delivery
Read the full study: The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and 3-AR knock-out mice (Endocrinology 2001)
Procter & Gamble Health Ltd manufactures Neurobion Forte Injection in GMP-certified facilities
What the Research Actually Shows Published research on AOD-9604 describes: Modest body fat reduction in preclinical and early clinical settings Reduced triglycerides in some studies Minimal effect on IGF-1 confirmed across the clinical dataset Good tolerability adverse event rates in the phase 2 obesity trials were comparable to placebo Variable weight loss some patients respond better than others, consistent with many metabolic interventions The effect size in phase 2 obesity trials was modest typically in the range of a few pounds over the study period
$182 Our Tesofensine research products are provided in a tabulated format, packaged in HDPE containers, protected with sterile cotton, sealed in a sterilized environment both at the cap and vacuum sealed on the outside for safety and protection during transit and storage
